Xtant Medical Holdings Company Profile (AMEX:XTNT)

About Xtant Medical Holdings (AMEX:XTNT)

Xtant Medical Holdings logoXtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. It also processes and distributes sports allografts, milled spinal allografts and allografts for multi-disciplinary applications.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: N/A
  • Symbol: AMEX:XTNT
  • CUSIP: N/A
  • Web: xtantmedical.com/
Capitalization:
  • Market Cap: $12.43 million
  • Outstanding Shares: 18,092,000
Average Prices:
  • 50 Day Moving Avg: $0.75
  • 200 Day Moving Avg: $0.66
  • 52 Week Range: $0.29 - $1.21
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.53
  • P/E Growth: -0.030
Sales & Book Value:
  • Annual Revenue: $91.05 million
  • Price / Sales: 0.14
  • Book Value: ($1.18) per share
  • Price / Book: -0.58
Profitability:
  • EBITDA: ($710,169.00)
  • Net Margins: -45.28%
  • Return on Assets: -28.38%
Misc:
  • Average Volume: 510,891 shs.
  • Short Ratio: 1.69
 

Frequently Asked Questions for Xtant Medical Holdings (AMEX:XTNT)

What is Xtant Medical Holdings' stock symbol?

Xtant Medical Holdings trades on the AMEX under the ticker symbol "XTNT."

How were Xtant Medical Holdings' earnings last quarter?

Xtant Medical Holdings Inc (AMEX:XTNT) issued its quarterly earnings results on Tuesday, May, 9th. The company reported ($0.29) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.01. The business earned $22.08 million during the quarter. View Xtant Medical Holdings' Earnings History.

Where is Xtant Medical Holdings' stock going? Where will Xtant Medical Holdings' stock price be in 2017?

2 brokers have issued 1 year price objectives for Xtant Medical Holdings' shares. Their forecasts range from $1.50 to $3.50. On average, they anticipate Xtant Medical Holdings' stock price to reach $2.50 in the next year. View Analyst Ratings for Xtant Medical Holdings.

Who are some of Xtant Medical Holdings' key competitors?

Who are Xtant Medical Holdings' key executives?

Xtant Medical Holdings' management team includes the folowing people:

  • Kent L. Swanson, Independent Chairman of the Board
  • Carl D. O'Connell, President, Chief Executive Officer
  • Darrel Lee Holmes, Chief Operating Officer
  • Gregory Juda Ph.D., Chief Scientific Officer
  • David Louis Kirschman M.D., Director
  • Paul R. Buckman, Independent Director
  • John Deedrick, Independent Director
  • Michael A. Lopach CPA, Independent Director
  • Rudy A. Mazzocchi, Independent Director

How do I buy Xtant Medical Holdings stock?

Shares of Xtant Medical Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Xtant Medical Holdings' stock price today?

One share of Xtant Medical Holdings stock can currently be purchased for approximately $0.69.


MarketBeat Community Rating for Xtant Medical Holdings (AMEX XTNT)
Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  60 (Vote Outperform)
Underperform Votes:  65 (Vote Underperform)
Total Votes:  125
MarketBeat's community ratings are surveys of what our community members think about Xtant Medical Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Xtant Medical Holdings (AMEX:XTNT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.50
Consensus Price Target History for Xtant Medical Holdings (AMEX:XTNT)
Price Target History for Xtant Medical Holdings (AMEX:XTNT)
Analysts' Ratings History for Xtant Medical Holdings (AMEX:XTNT)
Show:
DateFirmActionRatingPrice TargetDetails
5/22/2017Maxim GroupReiterated RatingBuy$1.50View Rating Details
11/30/2016AegisInitiated CoverageBuy$3.50View Rating Details
8/4/2016HC WainwrightReiterated RatingBuyView Rating Details
3/17/2016Brean CapitalReiterated RatingBuy$10.00View Rating Details
(Data available from 10/18/2015 forward)

Earnings

Earnings History for Xtant Medical Holdings (AMEX:XTNT)
Earnings by Quarter for Xtant Medical Holdings (AMEX:XTNT)
Earnings History by Quarter for Xtant Medical Holdings (AMEX XTNT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017Q1 2017($0.30)($0.29)$22.08 millionViewListenView Earnings Details
3/9/2017Q4 2016($0.30)($0.31)$24.45 million$24.47 millionViewListenView Earnings Details
5/4/2016Q1($0.39)($0.44)$21.94 million$20.98 millionViewN/AView Earnings Details
3/15/2016Q415($0.22)$0.97$23.34 million$22.30 millionViewN/AView Earnings Details
11/11/2015Q3($0.15)($0.64)$19.64 million$17.69 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Xtant Medical Holdings (AMEX:XTNT)
Current Year EPS Consensus Estimate: $-1.2900 EPS
Next Year EPS Consensus Estimate: $-0.4500 EPS

Dividends

Dividend History for Xtant Medical Holdings (AMEX:XTNT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Xtant Medical Holdings (AMEX:XTNT)
Insider Trades by Quarter for Xtant Medical Holdings (AMEX:XTNT)
Institutional Ownership by Quarter for Xtant Medical Holdings (AMEX:XTNT)
Insider Trades by Quarter for Xtant Medical Holdings (AMEX:XTNT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/9/2016Daniel S GoldbergerCEOBuy5,000$2.34$11,700.00View SEC Filing  
12/3/2015Kent L. SwansonDirectorBuy3,300$2.83$9,339.00View SEC Filing  
11/20/2015David Louis KirschmanEVPBuy2,000$2.99$5,980.00View SEC Filing  
11/20/2015Kent L. SwansonDirectorBuy5,000$3.00$15,000.00View SEC Filing  
11/19/2015David Louis KirschmanEVPBuy2,000$2.90$5,800.00View SEC Filing  
11/16/2015Daniel S GoldbergerCEOBuy3,000$2.80$8,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Xtant Medical Holdings (AMEX:XTNT)
Latest Headlines for Xtant Medical Holdings (AMEX:XTNT)
Source:
DateHeadline
globenewswire.com logoXtant Medical Announces Consolidation of Fixation Operations to Montana and Closure of Dayton Facility - GlobeNewswire (press release)
globenewswire.com - October 6 at 3:31 PM
finance.yahoo.com logoXtant Medical Announces Consolidation of Fixation Operations to Montana and Closure of Dayton Facility
finance.yahoo.com - October 6 at 3:31 PM
prnewswire.com logoToday's Research Report Coverage on Medical Equipment Stocks -- Varian Medical Systems, Senseonics, Xtant ... - PR Newswire (press release)
www.prnewswire.com - October 6 at 8:57 AM
finance.yahoo.com logoXtant Medical Holdings, Inc. :XTNT-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017
finance.yahoo.com - October 3 at 3:54 PM
streetinsider.com logoXtant Medical Holdings (XTNT) Granted 510k Clearance for Expanded Indications of Irix-A - StreetInsider.com
www.streetinsider.com - September 12 at 12:32 PM
finance.yahoo.com logoXtant Medical Receives 510k Clearance for Expanded Indications of Irix-A
finance.yahoo.com - September 12 at 12:32 PM
seekingalpha.com logoXtant Medical Holdings' (XTNT) CEO Carl O'Connell on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 11 at 9:16 AM
finance.yahoo.com logoInvestor Network: Xtant Medical Holdings, Inc. to Host Earnings Call
finance.yahoo.com - August 11 at 9:16 AM
finance.yahoo.com logoEdited Transcript of XTNT earnings conference call or presentation 10-Aug-17 2:00pm GMT
finance.yahoo.com - August 11 at 9:16 AM
streetinsider.com logoXtant Medical Holdings (XTNT) Reports Q2 Loss of $0.54
www.streetinsider.com - August 10 at 1:28 AM
globenewswire.com logoXtant Medical Reports Second Quarter 2017 Financial Results - GlobeNewswire (press release)
globenewswire.com - August 9 at 8:27 PM
globenewswire.com logoXtant Medical Receives FDA Clearance for Calix-C Cervical Interbody Line Extension and Expanded Indications - GlobeNewswire (press release)
globenewswire.com - August 9 at 8:27 PM
finance.yahoo.com logoXtant Medical Reports Second Quarter 2017 Financial Results
finance.yahoo.com - August 9 at 8:27 PM
streetinsider.com logoXtant Medical Holdings (XTNT) Says it Received FDA Clearance for Calix-C Cervical Interbody Line Extension and ... - StreetInsider.com
www.streetinsider.com - August 9 at 3:25 PM
nasdaq.com logoXtant Medical Receives FDA Clearance for Calix-C Cervical Interbody Line Extension and Expanded Indications - Nasdaq
www.nasdaq.com - August 9 at 9:27 AM
finance.yahoo.com logoXtant Medical Receives FDA Clearance for Calix-C Cervical Interbody Line Extension and Expanded Indications
finance.yahoo.com - August 9 at 9:27 AM
globenewswire.com logoXtant Medical Joins the 2018 Donate Life Rose Parade Float to Highlight the Power of Organ, Eye, and Tissue Donation - GlobeNewswire (press release)
globenewswire.com - August 4 at 10:17 AM
finance.yahoo.com logoXtant Medical Joins the 2018 Donate Life Rose Parade Float to Highlight the Power of Organ, Eye, and Tissue Donation
finance.yahoo.com - August 3 at 9:06 AM
americanbankingnews.com logoXtant Medical Holdings Inc (XTNT) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - August 2 at 7:22 AM
globenewswire.com logoXtant Medical to Announce Second Quarter 2017 Results on August 9th, 2017 - GlobeNewswire (press release)
globenewswire.com - July 25 at 8:47 AM
americanbankingnews.com logoXtant Medical Holdings Inc (AMEX:XTNT) Set to Announce Earnings on Monday
www.americanbankingnews.com - July 24 at 8:18 AM
prnewswire.com logoAsset Acquisitions Accelerate in Healthcare Sector Boosting Potential Revenue Growth - PR Newswire (press release)
www.prnewswire.com - July 11 at 9:54 AM
prnewswire.com logoMedical Equipment Stock Performance Review -- Xtant Medical, Second Sight Medical Products, Lantheus, and Masimo - PR Newswire (press release)
www.prnewswire.com - July 5 at 8:26 PM
investorplace.com logoWhole Foods Market, Inc. (WFM) and Xtant Medical Holdings Inc (XTNT) Lead 13 Activist Investment Filings
investorplace.com - May 31 at 10:17 AM
globenewswire.com logoXtant Medical Announces Rescheduling of Annual Meeting - GlobeNewswire (press release)
globenewswire.com - May 27 at 6:56 AM
seekingalpha.com logoXtant Medical in-licenses Sites Medical's OsteoSync Ti
seekingalpha.com - May 17 at 12:15 AM
streetinsider.com logoXtant Medical Holdings (XTNT) Announces Licensing Agreement for Sites Medical's OsteoSync Ti Technology - StreetInsider.com
www.streetinsider.com - May 16 at 8:03 AM
seekingalpha.com logoXtant Medical Holdings' (XTNT) CEO Carl O'Connell on Q1 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 15 at 8:17 AM
seekingalpha.com logoXtant Medical Holdings, Inc. 2017 Q1 - Results - Earnings Call Slides
seekingalpha.com - May 14 at 12:06 PM
reuters.com logoBRIEF-Xtant, units entered forbearance agreement with Silicon Valley Bank
www.reuters.com - April 25 at 8:25 AM
biz.yahoo.com logoXTANT MEDICAL HOLDINGS, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 30 at 8:31 AM
biz.yahoo.com logoQ4 2016 Xtant Medical Holdings Inc Earnings Release - After Market Close
biz.yahoo.com - March 10 at 6:43 AM
seekingalpha.com logoXTNT @ 35c This Low Floater Could Be A Big Gainer In 2017 And Beyond. Analysts Average PT Is $3.1/Share
seekingalpha.com - February 2 at 6:56 AM
streetinsider.com logoXtant Medical Holdings (XTNT) Announces Resignation of CEO Dan Goldberger
www.streetinsider.com - January 24 at 5:26 AM
seekingalpha.com logoXtant Medical chief bids adieu
seekingalpha.com - January 24 at 5:26 AM
biz.yahoo.com logoXTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or P
biz.yahoo.com - January 24 at 5:26 AM
biz.yahoo.com logoXTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fin
biz.yahoo.com - January 21 at 6:01 AM
seekingalpha.com logoXtant Medical issues new convertible debt to cover $1.6M in interest obligations
seekingalpha.com - January 19 at 4:32 PM
us.rd.yahoo.com logoCoverage initiated on Xtant Medical by Maxim Group
us.rd.yahoo.com - December 8 at 2:19 PM

Social

Social activity is not available for this stock.

Chart

Xtant Medical Holdings (XTNT) Chart for Wednesday, October, 18, 2017

This page was last updated on 10/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.